At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 20 enrolled

Drug / intervention

Thoracic epidural (ropivicaine, fentanyl) +1 moredrug

Likely dose

Thoracic epidural (ropivicaine, fentanyl) 2 mgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02721017

NCT02721017Phase 4Completed

Compare CT.gov

Pain Control in the Nuss Procedure: A Prospective, Randomized Trial of Cryoanalgesia vs. Thoracic Epidural

University of California, San Francisco·interventional·Posted Mar 28, 2016·Updated May 5, 2021

In Brief

A Phase 4 clinical trial evaluating Cryoanalgesia and Thoracic epidural (ropivicaine, fentanyl) for Pectus Excavatum and Funnel Chest. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether cryoanalgesia provides better pain control for minimally invasive pectus excavatum repair (the Nuss procedure) than thoracic epidural.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsPectus Excavatum, Funnel Chest

CountriesUnited States

CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Food and Drug Administration (FDA)

Timeline

Phase 4CompletedFinished

20162017201820192020202120222023202420252026

First PostedMar 2016

Enrollment StartMay 2016

Primary CompletionAug 2018

Study CompletionSep 2018

TodayJul 2026

First PostedMar 28, 2016

Enrollment StartMay 1, 2016

Primary CompletionAug 28, 2018

Study CompletionSep 1, 2018

TodayJul 2, 2026

Enrollment to primary: 2.3 yearsPosted 10.3 years ago

Interventions

Cryoanalgesiadevice

Thoracic epidural (ropivicaine, fentanyl)drug

Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.